These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 12413987)

  • 1. Naloxone decreases insulin secretion in hyperinsulinemic postmenopausal women and may positively affect hormone replacement therapy.
    Cucinelli F; Soranna L; Perri C; Romualdi D; Barini A; Mancuso S; Lanzone A
    Fertil Steril; 2002 Nov; 78(5):1017-24. PubMed ID: 12413987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effect of transdermal estrogen plus progestagen replacement therapy on insulin metabolism in postmenopausal women: relation to their insulinemic secretion.
    Cucinelli F; Paparella P; Soranna L; Barini A; Cinque B; Mancuso S; Lanzone A
    Eur J Endocrinol; 1999 Mar; 140(3):215-23. PubMed ID: 10216516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of naltrexone in postmenopausal women with exaggerated insulin secretion: a pilot study.
    Cucinelli F; Soranna L; Perri C; Barini A; Cento RM; Mancuso S; Lanzone A
    Fertil Steril; 2004 Apr; 81(4):1047-54. PubMed ID: 15066462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tibolone and cyclic hormone replacement therapy on glucose metabolism in non-diabetic obese postmenopausal women: a randomized study.
    Morin-Papunen LC; Vauhkonen I; Ruokonen A; Tapanainen JS; Raudaskoski T
    Eur J Endocrinol; 2004 May; 150(5):705-14. PubMed ID: 15132728
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of raloxifene on glyco-insulinemic homeostasis in healthy postmenopausal women: a randomized placebo-controlled study.
    Cucinelli F; Soranna L; Romualdi D; Muzj G; Mancuso S; Lanzone A
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4186-92. PubMed ID: 12213869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of hormone replacement therapy on insulin secretion and insulin sensitivity in postmenopausal diabetic women.
    Borissova AM; Tankova T; Kamenova P; Dakovska L; Kovacheva R; Kirilov G; Genov N; Milcheva B; Koev D
    Gynecol Endocrinol; 2002 Feb; 16(1):67-74. PubMed ID: 11915585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose hormone therapy and carbohydrate metabolism.
    Li C; Samsioe G; Borgfeldt C; Bendahl PO; Wilawan K; Aberg A
    Fertil Steril; 2003 Mar; 79(3):550-5. PubMed ID: 12620438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of the opioid blockade on the feeding-induced growth hormone response to growth hormone-releasing hormone in women with polycystic ovary syndrome.
    Guido M; Romualdi D; Mancini A; Lattanzi F; Villa P; Barini A; Lanzone A; De Marinis L
    Fertil Steril; 2002 Nov; 78(5):994-1000. PubMed ID: 12413983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of continuous combined estradiol-norethisterone acetate preparations on insulin sensitivity in postmenopausal nondiabetic women.
    Kimmerle R; Heinemann L; Heise T; Bender R; Weyer C; Hirschberger S; Berger M
    Menopause; 1999; 6(1):36-42. PubMed ID: 10100178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of opioid antagonists in the treatment of women with glucoregulation abnormalities.
    Guido M; Romualdi D; Lanzone A
    Curr Pharm Des; 2006; 12(8):1001-12. PubMed ID: 16533167
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hormone replacement therapy, insulin sensitivity, and abdominal obesity in postmenopausal women.
    Ryan AS; Nicklas BJ; Berman DM
    Diabetes Care; 2002 Jan; 25(1):127-33. PubMed ID: 11772913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individual effect of E2 and dydrogesterone on insulin sensitivity in post-menopausal women.
    Soranna L; Cucinelli F; Perri C; Muzj G; Giuliani M; Villa P; Lanzone A
    J Endocrinol Invest; 2002 Jun; 25(6):547-50. PubMed ID: 12109627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of the effects of oral and transdermal estrogen replacement on insulin sensitivity in postmenopausal women.
    O'Sullivan AJ; Ho KK
    J Clin Endocrinol Metab; 1995 Jun; 80(6):1783-8. PubMed ID: 7775623
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of opioid blockade on insulin and growth hormone (GH) secretion in patients with polycystic ovary syndrome: the heterogeneity of impaired GH secretion is related to both obesity and hyperinsulinism.
    Villa P; Valle D; Mancini A; De Marinis L; Pavone V; Fulghesu AM; Mancuso S; Lanzone A
    Fertil Steril; 1999 Jan; 71(1):115-21. PubMed ID: 9935127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of raloxifene on insulin sensitivity, beta-cell function, and hepatic insulin extraction in normal postmenopausal women.
    Nagamani M; Szymajda A; Sepilian V; Urban RJ; Gilkison C
    Fertil Steril; 2008 Mar; 89(3):614-9. PubMed ID: 17586504
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-acetyl-cysteine treatment improves insulin sensitivity in women with polycystic ovary syndrome.
    Fulghesu AM; Ciampelli M; Muzj G; Belosi C; Selvaggi L; Ayala GF; Lanzone A
    Fertil Steril; 2002 Jun; 77(6):1128-35. PubMed ID: 12057717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women.
    Gaspard UJ; Wery OJ; Scheen AJ; Jaminet C; Lefebvre PJ
    Climacteric; 1999 Jun; 2(2):93-100. PubMed ID: 11910673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of insulin secretion in relation to insulin sensitivity in nondiabetic postmenopausal women.
    Ahrén B; Larsson H
    Diabetes; 2002 Feb; 51 Suppl 1():S202-11. PubMed ID: 11815481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome.
    Guido M; Pavone V; Ciampelli M; Murgia F; Fulghesu AM; Apa R; Caruso A; Mancuso S; Lanzone A
    J Clin Endocrinol Metab; 1998 May; 83(5):1742-5. PubMed ID: 9589685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naloxone does not influence cardiovascular responses to mild mental stress in postmenopausal women.
    Litschauer B; Schaller G; Wolzt M
    Am J Physiol Heart Circ Physiol; 2005 Nov; 289(5):H2120-5. PubMed ID: 15994852
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.